Dispensing GPs drop Pfizer in supply row

Dispensing practices across the UK have cut their use of Pfizer medicines after the firm switched to a new supply arrangement that cuts practice profits, GPs say.

Dr David Baker, chief executive of the DDA
Dr David Baker, chief executive of the DDA

Pfizer stopped using pharmaceutical wholesalers that have traditionally supplied drugs to dispensing practices, and switched to a single supply firm earlier this year (Drug cost increases for dispensing GPs - GP, 9 March).

The move brought to an end discount deals the practices had negotiated with wholesalers, and cut practice profits.

Dispensing practices have responded with a partial boycott of Pfizer products.

'Every practice will have reviewed their use of Pfizer drugs and if there are changes they can make without affecting patient care or the cost to the NHS, they are likely to do so,' said Dr David Baker, chief executive of the Dispensing Doctors' Association (DDA).

nick.bostock@haymarket.com

What do you think? Comment below or email us at healthcare.republic@haymarket.com  

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in